HY-10161-100mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
HY-10161-250mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
HY-10161-50mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
HY-104000-10mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
HY-104000-100mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
HY-104000-25mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
HY-104000-5mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
HY-104000-50mg
|
MedChemexpress LLC
|
BAY-320 [CAS 1445830-50-1]
|
|
Cancer-programmed cell death
|
|
HY-10505-10mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-10505-25mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-10505-5mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-10505-50mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-108465-10mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
HY-108465-25mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
HY-108465-5mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
HY-108465-50mg
|
MedChemexpress LLC
|
Pyr3 [CAS 1160514-60-2]
|
|
|
|
HY-112815-10mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-112815-100mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-112815-25mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-112815-5mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-112815-50mg
|
MedChemexpress LLC
|
ALK2-IN-2 [CAS 2254409-25-9]
|
|
Neuroscience-Neuromodulation
|
|
HY-117727A-5mg
|
MedChemexpress LLC
|
Leriglitazone (hydrochloride) [CAS 146062-46-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-122652-100mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-122652-25mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-122652-50mg
|
MedChemexpress LLC
|
MitoBloCK-6 [CAS 303215-67-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|